Neuronetics, Inc. (STIM)

↓ Download CSV

CIK 0001227636 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Neuronetics, Inc. reported revenue of $149.16M, up 99.2% from the prior year. The company ran a net loss, with a net margin of -26.1% and a gross margin of 48.5%. It held $141.55M in total assets against $115.31M in total liabilities.

Key ratios (FY2025)

48.5%
Gross margin
-21.1%
Operating margin
-26.1%
Net margin
-174.3%
Return on equity
+99.2%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$149.16M$74.89M$71.35M$65.21M$55.31M$49.24M$62.66M$52.78M$40.43M
Cost of Revenue$76.85M$20.73M$19.64M$15.48M$11.65M$11.55M$15.39M$12.45M$9.63M
Gross Profit$72.31M$54.16M$51.70M$49.72M$43.66M$37.69M$47.27M$40.33M$30.80M$27.61M
Operating Income-$31.44M-$34.56M-$30.55M-$35.11M-$27.56M-$22.31M-$26.93M-$19.83M-$13.61M-$9.34M
Net Income-$39.00M-$43.71M-$30.19M-$37.16M-$31.19M-$27.45M-$29.04M-$24.10M-$16.06M-$11.23M
EPS (Diluted)$-0.59$-1.38$-1.05$-1.38$-1.22$-1.46$-1.58
Total Assets$141.55M$140.90M$115.83M$116.88M$141.22M$78.66M$100.17M$117.02M$38.94M
Total Liabilities$115.31M$109.10M$81.64M$59.82M$56.05M$53.16M$52.32M$45.98M$44.45M
Shareholders' Equity$22.38M$27.71M$34.19M$57.06M$85.17M$25.49M$47.85M$71.04M-$192.65M-$177.12M
Cash & Equivalents$28.13M$18.46M$59.68M$70.34M$94.14M$48.96M$75.71M$104.58M$29.15M
Operating Cash Flow-$20.37M-$31.00M-$32.04M-$30.74M-$27.98M-$28.39M-$30.48M-$20.59M-$11.14M-$8.54M
Capital Expenditures$801.0K$1.47M$2.37M$3.27M$2.35M$730.0K$813.0K$1.01M$594.0K$324.0K
Shares Outstanding68.99M55.68M29.09M27.27M26.39M19.11M18.64M17.74M231.0K